Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00049140 · ClinicalTrials.gov registry record · Phase 2
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
A Phase 2 study, sponsored by David M. Brizel, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00049140 is a Phase 2 study that has completed, run by David M. Brizel, MD. The registered enrollment target is 8 participants.
The verdict
NCT00049140, a Phase 2 study, has completed, sponsored by David M. Brizel, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures using the drug EF5 to detect the presence of oxygen in tumor cells may help to plan effective treatment for solid tumors. PURPOSE: Phase II trial to compare diagnostic procedures using EF5 to that of other methods of detecting oxygen levels in tumor cells of patients who have head and neck cancer.
Interventions
- PROCEDURE biopsy
- OTHER immunohistochemistry staining method
- OTHER flow cytometry
- DRUG EF5
- OTHER bioluminescence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2002-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00049140
The ClinicalTrials.gov registry entry for NCT00049140 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David M. Brizel, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which biopsy is the first listed.
NCT00049140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00049140 about?
NCT00049140 is a clinical study titled "EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer". RATIONALE: Diagnostic procedures using the drug EF5 to detect the presence of oxygen in tumor cells may help to plan effective treatment for solid tumors. PURPOSE: Phase II trial to compare diagnostic procedures using EF5 to that of other methods of detecting oxygen levels in tumor cells of patient...
What is the current status of trial NCT00049140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2002-08.
What interventions are being tested in trial NCT00049140?
The interventions under investigation include: biopsy (PROCEDURE), immunohistochemistry staining method (OTHER), flow cytometry (OTHER), EF5 (DRUG), bioluminescence (OTHER).
Who is sponsoring clinical trial NCT00049140?
This trial is sponsored by David M. Brizel, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.